Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xenon Pharmaceuticals

37.80
+0.18000.48%
Volume:425.04K
Turnover:16.08M
Market Cap:2.89B
PE:-12.57
High:38.55
Open:37.65
Low:37.45
Close:37.62
Loading ...

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus

Zacks
·
13 Nov 2024

Stifel Nicolaus Reaffirms Their Buy Rating on Xenon (XENE)

TIPRANKS
·
13 Nov 2024

Xenon Pharmaceuticals Inc : Wedbush Cuts Target Price to $46 From $49

THOMSON REUTERS
·
13 Nov 2024

RBC Capital Sticks to Its Buy Rating for Xenon (XENE)

TIPRANKS
·
13 Nov 2024

Xenon Pharmaceuticals Price Target Maintained With a $60.00/Share by Needham

Dow Jones
·
13 Nov 2024

Xenon Pharmaceuticals Inc (XENE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...

GuruFocus.com
·
13 Nov 2024

TD Cowen Keeps Their Buy Rating on Xenon (XENE)

TIPRANKS
·
13 Nov 2024

Xenon Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024

Xenon Advances Epilepsy and Depression Programs

TIPRANKS
·
13 Nov 2024

Xenon Pharmaceuticals Q3 Net Loss Widens

MT Newswires Live
·
13 Nov 2024

Xenon Pharmaceuticals reports Q3 EPS (81c), consensus (81c)

TIPRANKS
·
13 Nov 2024

Xenon Pharmaceuticals: Q3 Earnings Snapshot

Associated Press Finance
·
13 Nov 2024

Xenon Pharmaceuticals Q3 2024 GAAP EPS $(0.81), Inline

Benzinga
·
13 Nov 2024

Xenon Pharmaceuticals Inc Q3 Shr View $-0.82 -- Lseg Ibes Data

THOMSON REUTERS
·
13 Nov 2024

Xenon Pharmaceuticals Qtrly Shr Loss $0.81

THOMSON REUTERS
·
13 Nov 2024

Xenon Pharmaceuticals Q3 Pretax Profit USD -63.11 Million VS. Ibes Estimate USD -63 Million

THOMSON REUTERS
·
13 Nov 2024

Xenon Pharmaceuticals Inc expected to post a loss of 82 cents a share - Earnings Preview

Reuters
·
09 Nov 2024

Xenon to Report Q3 2024 Financial Results on November 12, 2024

GlobeNewswire
·
06 Nov 2024